← Back to all trials
Active Not Recruiting
NCT05096182
Long-Term Follow-up of Patients With Chronic Kidney Disease Treated With Cellgram-CKD
Conditions: Chronic Kidney Disease
Sex: All
Ages: 19 Years – 79 Years
Healthy volunteers: No
Enrollment: 10
Sponsor: Pharmicell Co., Ltd.
Location: Asan Medical Center Hospital Seoul
Summary
This long-term follow-up study is a 5-year long-term follow-up study to evaluate long-term safety in Cellgram-CKD subjects. (refer to ClinicalTrials.gov. Identifier: NCT05042206).
Eligibility Criteria
Inclusion Criteria:
* Those who participated in the PMC-P-12 clinical trial and received Cellgram-CKD
* Subjects who consented in writing to this long-term follow-up study
Exclusion Criteria:
* Not Applicable
Source: ClinicalTrials.gov (NCT05096182). StuddyBuddy aggregates publicly available trial information.
